Neuropeptides and inflammatory bowel disease
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory condition, the pathophysiology of which is not well understood. It has, however, become increasingly evident that interactions between the enteric nervous system and the immune system play an important role in the cause of IBD. Both the enteric nervous system and the central nervous system can amplify or modulate the aspects of intestinal inflammation through secretion of neuropeptides or small molecules. The purpose of this study is to present recent data on the role that neuropeptides play in the pathophysiology of IBD. RECENT FINDINGS: The best studied of the neuropeptides thought to play a role in the pathogenesis of IBD include substance P, corticotropin-releasing hormone, neurotensin, and vasoactive intestinal peptide; small molecules include acetylcholine and serotonin. Recently discovered functions of each of these neuropeptides with a discussion of implications of the data for therapy are reviewed. SUMMARY: Although the available data suggest an important role for neuropeptides in the pathophysiology of intestinal inflammation, there does yet not appear to be a function that can be taken as established for any of these molecules. The complexity of neuroimmune-endocrine systems, conflicting study results and dual mechanisms of action, warrant further research in this field. Clarification of the molecular mechanisms of action of neuropeptides and on immune and inflammatory reactions will likely yield new treatment options in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Collins, S. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70034-3 · Cited by 511
Enteric neuroplasticity evoked by inflammation
Vasina, V., Barbara, G., Talamonti, L., Stanghellini, V., Corinaldesi, R., Tonini, M., De Ponti, F., & De Giorgio, R. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.02.025 · Cited by 221
Bischoff, S. C., Mailer, R., Pabst, O., Weier, G., Sedlik, W., Li, Z., Chen, J. J., Murphy, D. L., & Gershon, M. D. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90685.2008 · Cited by 206
The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions
Bienenstock, J., Tomioka, M., Matsuda, H., Stead, R. H., Quinonez, G., Simon, G. T., Coughlin, M. D., & Denburg, J. A. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000234197 · Cited by 193
Enteric nervous system abnormalities in inflammatory bowel diseases
Villanacci, V., Bassotti, G., Nascimbeni, R., Antonelli, E., Cadei, M., Fisogni, S., Salerni, B., & Geboes, K. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01146.x · Cited by 177
IL1β‐ and LPS‐induced serotonin secretion is increased in EC cells derived from Crohn’s disease
Kidd, M., Gustafsson, B. I., Drozdov, I., & Modlin, I. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01210.x · Cited by 130
The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis
Mawdsley, J. E., Jenkins, D. G., Macey, M. G., Langmead, L., & Rampton, D. S. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01845.x · Cited by 102
Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis
Chandrasekharan, B., Bala, V., Kolachala, V. L., Vijay-Kumar, M., Jones, D., Gewirtz, A. T., Sitaraman, S. V., & Srinivasan, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003304 · Cited by 70
Cited by
Relationship between the gut microbiome and brain function
Mohajeri, M. H., La Fata, G., Steinert, R. E., & Weber, P. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy009 · Cited by 376
“Both the ENS and the CNS can modulate intestinal inflammation through secretion of neuropeptides or other soluble molecules.(164) In addition, the innervation of the GI tract by the sympathetic nervous system controls the motility, fluid exchange, and blood flow in the gut of healthy individuals.”
GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation
Auteri, M., Zizzo, M. G., & Serio, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2014.12.001 · Cited by 307
Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis
Geboes, K., & Collins, S. (1998) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.1998.00102.x · Cited by 255
Neuroinflammation in inflammatory bowel disease
Lakhan, S. E., & Kirchgessner, A. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-37 · Cited by 217
“Chemical messengers that have been implicated in IBD include neuropeptides and small molecules such as acetylcholine (ACh) and 5-hydroxytryptamine (5-HT or serotonin) [39].”
Pellegrini, C., Fornai, M., Colucci, R., Tirotta, E., Blandini, F., Levandis, G., Cerri, S., Segnani, C., Ippolito, C., Bernardini, N., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0608-5 · Cited by 91
Metadata
- Authors
- Margolis, K. G., & Gershon, M. D.
- Venue
- Current Opinion in Gastroenterology
- Published
- 2009-11
- Volume
- 25
- Issue
- 6
- Pages
- 503-511
- ISSN
- 0267-1379 (ISSN-L)
- OpenAlex
- W2026987288
- Cited by
- 106
- References
- 11
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuropeptides and inflammatory bowel disease. https://app.cochat.ai/papers/10.1097/mog.0b013e328331b69e
- The paper
- Margolis, K. G., & Gershon, M. D. (2009). Neuropeptides and inflammatory bowel disease. Current Opinion in Gastroenterology. https://doi.org/10.1097/mog.0b013e328331b69e
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.